Brevan Howard Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$300K	Buy	+32,328	New	+$300K	﹤0.01%	1462
2025 Q1	–	Sell	-24,078	Closed	-$206K	–	1325
2024 Q4	$206K	Buy	+24,078	New	+$206K	﹤0.01%	876
2024 Q1	–	Sell	-20,121	Closed	-$89.7K	–	1202
2023 Q4	$89.7K	Buy	+20,121	New	+$89.7K	﹤0.01%	922